|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| G01N 33/6848 | (2013.01) | ||
| G01N 33/6815 | (2013.01) | ||
| G01N 33/6854 | (2013.01) |
| (11) | Number of the document | 3857237 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20706372.8 |
| Date of filing the European patent application | 2020-01-16 | |
| (97) | Date of publication of the European application | 2021-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/013907 |
| Date | 2020-01-16 |
| (87) | Number | WO 2020/150491 |
| Date | 2020-07-23 |
| (30) | Number | Date | Country code |
| 201962792994 P | 2019-01-16 | US |
| (72) |
WANG, Shunhai , US
|
| (73) |
REGENERON PHARMACEUTICALS, INC. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (54) | METHODS FOR CHARACTERIZING DISULFIDE BONDS |
| METHODS FOR CHARACTERIZING DISULFIDE BONDS |